Carrick’s GDPR Commitment Statement

The General Data Protection Regulation (GDPR) is the latest EU data privacy and protection framework which is effective from 25th of May 2018.

Carrick Therapeutics Limited is a biopharmaceutical company headquartered at NovaUCD, Dublin, focusing on the innovative research and development of transformative oncology medicines, and whilst we process very little Personal Data, we are committed to ensuring that it is collected, processed, stored and disposed of in line with GDPR standards.

We are committed to GDPR compliance including building GDPR into our current and future processes and our contractual commitments with our customers, suppliers, partners, applicants and employees.